Literature DB >> 27858200

Advanced oxidation protein products induce chondrocyte death through a redox-dependent, poly (ADP-ribose) polymerase-1-mediated pathway.

Wenbin Ye1, Zhaoming Zhong2, Siyuan Zhu2, Shuai Zheng2, Jun Xiao3, Shaolian Song4, Hui Yu2, Qian Wu2, Zhen Lin2, Jianting Chen5.   

Abstract

This study aimed to investigate the effect of AOPPs on apoptosis in human chondrocytes. Chondrocytes were treated with AOPPs. Cell death, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, reactive oxygen species (ROS) generation, and the expression of apoptotic proteins were detected in vitro. AOPPs levels were detected by colorimetric method. The results in vitro demonstrated that AOPPs induced cell death in human chondrocyte through a redox-dependent pathway, including RAGE-mediated, NADPH oxidase-dependent ROS generation, and poly (ADP-ribose) polymerase-1 (PARP-1) activation. Targeting AOPPs-induced cellular mechanisms might emerge as a promising therapeutic option for patients with RA.

Entities:  

Keywords:  Advanced oxidation protein production (AOPPs); Apoptosis; Chondrocytes; Oxidative stress; PARP-1; Rheumatoid arthritis

Mesh:

Substances:

Year:  2017        PMID: 27858200     DOI: 10.1007/s10495-016-1314-6

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  3 in total

Review 1.  Insights on Molecular Mechanisms of Chondrocytes Death in Osteoarthritis.

Authors:  Edith Charlier; Biserka Relic; Céline Deroyer; Olivier Malaise; Sophie Neuville; Julie Collée; Michel G Malaise; Dominique De Seny
Journal:  Int J Mol Sci       Date:  2016-12-20       Impact factor: 5.923

2.  Mitochondrial ROS contribute to oridonin-induced HepG2 apoptosis through PARP activation.

Authors:  Xiaoning Liu; Jingjing Kang; Hui Wang; Tao Huang
Journal:  Oncol Lett       Date:  2017-12-20       Impact factor: 2.967

Review 3.  Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis.

Authors:  Jianan Zhao; Ping Jiang; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.